S-23

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
S-23
DrugBank Accession Number
DB07419
Background

An androgen receptor modulator.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 416.754
Monoisotopic: 416.055082819
Chemical Formula
C18H13ClF4N2O3
Synonyms
  • (+)-S-23
  • (2S)-3-(4-Chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
  • CCTH-methylpropionamide
External IDs
  • (+)-S-23
  • S 23
  • S-23

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UAndrogen receptorNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Trifluoromethylbenzenes
Direct Parent
Trifluoromethylbenzenes
Alternative Parents
Anilides / Benzonitriles / N-arylamides / Phenol ethers / Phenoxy compounds / Fluorobenzenes / Chlorobenzenes / Alkyl aryl ethers / Aryl fluorides / Aryl chlorides
show 10 more
Substituents
Alcohol / Alkyl aryl ether / Alkyl fluoride / Alkyl halide / Anilide / Aromatic homomonocyclic compound / Aryl chloride / Aryl fluoride / Aryl halide / Benzonitrile
show 25 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
XDK89456WM
CAS number
1010396-29-8
InChI Key
SSFVOEAXHZGTRJ-KRWDZBQOSA-N
InChI
InChI=1S/C18H13ClF4N2O3/c1-17(27,9-28-12-4-5-14(19)15(20)7-12)16(26)25-11-3-2-10(8-24)13(6-11)18(21,22)23/h2-7,27H,9H2,1H3,(H,25,26)/t17-/m0/s1
IUPAC Name
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
SMILES
C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F

References

General References
Not Available
PubChem Compound
24892822
PubChem Substance
99443890
ChemSpider
24715019
BindingDB
26261
ChEMBL
CHEMBL512283
ZINC
ZINC000039037278
PDBe Ligand
B5R
Wikipedia
S-23_(drug)
PDB Entries
3b5r

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00426 mg/mLALOGPS
logP3.68ALOGPS
logP4.16Chemaxon
logS-5ALOGPS
pKa (Strongest Acidic)11.95Chemaxon
pKa (Strongest Basic)-4Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area82.35 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity94.35 m3·mol-1Chemaxon
Polarizability36.22 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9942
Blood Brain Barrier+0.658
Caco-2 permeable-0.5681
P-glycoprotein substrateNon-substrate0.5382
P-glycoprotein inhibitor INon-inhibitor0.6054
P-glycoprotein inhibitor IINon-inhibitor0.8077
Renal organic cation transporterNon-inhibitor0.9474
CYP450 2C9 substrateNon-substrate0.7569
CYP450 2D6 substrateNon-substrate0.7382
CYP450 3A4 substrateNon-substrate0.5054
CYP450 1A2 substrateNon-inhibitor0.51
CYP450 2C9 inhibitorNon-inhibitor0.5212
CYP450 2D6 inhibitorNon-inhibitor0.7816
CYP450 2C19 inhibitorInhibitor0.6776
CYP450 3A4 inhibitorNon-inhibitor0.799
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5957
Ames testNon AMES toxic0.7935
CarcinogenicityNon-carcinogens0.8003
BiodegradationNot ready biodegradable1.0
Rat acute toxicity2.4004 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9852
hERG inhibition (predictor II)Non-inhibitor0.7481
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000i-3931000000-503d215c2c527cfccd93
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014j-0054900000-a09501fc3c4551041090
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kr-0934700000-b411ad29e70331a275f1
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-000l-5940200000-116abf8b04e0a9130e49
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0uxr-0192200000-e5b56ee4a510a81c7627
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-000l-4910000000-76d1387edba0877c3fb2
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-2980000000-d17a503f9ab5575634d3
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-183.87254
predicted
DeepCCS 1.0 (2019)
[M+H]+186.23055
predicted
DeepCCS 1.0 (2019)
[M+Na]+192.75034
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details
1. Androgen receptor
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Zinc ion binding
Specific Function
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription ...
Gene Name
AR
Uniprot ID
P10275
Uniprot Name
Androgen receptor
Molecular Weight
98987.9 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52